Latest Breaking News On - Central park teaching hospital - Page 1 : comparemela.com

YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer, today announced the completion of subject enrollment in its Phase 3 clinical trial (the "Phase 3 Trial" or the "Trial") of the Company's PIKA Rabies Vaccine. The Trial, which will assess the safety, immunogenicity, and lot-to-lot consis

United statesAlyssa liMuhammad ahmadRobin yangZenaida mojaresRalph villalobosSource ys biopharma co ltdSecurities exchangePrincipal investigatorCentral park teaching hospitalPhilippine general hospitalChief medical officerSecurities actSecurities exchange actPrivate securities litigation reform actBusiness combination